Evelo Biosciences, Inc. ( EVLO) - Key Metrics
EVLO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0 | -$71.12 | -$59.87 | -$60.14 |
| 2023Q2 | $0 | -$3.78 | -$3.55 | -$3.55 |
| 2023Q1 | $0 | -$4.57 | -$3.66 | -$3.66 |
| 2022Q4 | $0 | -$4.29 | -$4.22 | -$4.26 |
| 2022Q3 | $0 | -$5.66 | -$4.18 | -$4.18 |
EVLO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -0.01 |
| 2023Q2 | 0% | -0.21 |
| 2023Q1 | 0% | -0.20 |
| 2022Q4 | 0% | -1.88 |
| 2022Q3 | 0% | -1.85 |
EVLO
Price: $0
52 week price:
Earnings Per Share: -19.55 USD
P/E Ratio: -1.81
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71715
Market Capitalization: 1898